Ukraine says it's ready to restart talks with Russia but needs clarity on Kremlin's terms
KYIV, Ukraine — Ukraine is ready to resume direct peace talks with Russia in Istanbul on Monday, a top adviser to President Volodymyr Zelenskyy said, following days of uncertainty over whether Kyiv would attend a meeting proposed by Moscow.
But Ukrainian officials have insisted that the Kremlin provide a promised memorandum setting out its position on ending the more than three-year war, before the two delegations sit down to negotiate.
'Ukraine is ready to attend the next meeting, but we want to engage in a constructive discussion,' Andrii Yermak said in a statement on the website of Ukraine's Presidential Office late Thursday.
'This means it is important to receive Russia's draft. There is enough time – four days are sufficient for preparing and sending the documents,' Yermak said.
Ukraine and its European allies have repeatedly accused the Kremlin of dragging its feet in peace efforts, while it tries to press its bigger army's battlefield initiative and capture more Ukrainian land.
Kyiv's Western partners, including the U.S., are urging Moscow to agree to an unconditional ceasefire, something Kyiv has embraced while the Kremlin has held out for terms more to its liking.
Ukraine's top diplomat, Andrii Sybiha, also told reporters on Friday that Kyiv is waiting for Russia to clarify its proposals ahead of a next round of talks.
'We want to end this war this year. We are interested in establishing a ceasefire, whether it is for 30 days, 50 days, or 100 days. Ukraine is open to discussing this directly with Russia,' Sybiha said at a joint news conference in Kyiv with his Turkish counterpart, Hakan Fidan.
Sybiha and Fidan also held the door open to a future meeting between Presidents Zelenskyy and Vladimir Putin of Russia, possibly also including U.S. President Donald Trump. Fidan said the ongoing peace push in Istanbul could be 'crowned with' such a meeting.
Kremlin spokesman Dmitry Peskov on Friday told reporters that a Russian delegation will head to Istanbul and stand ready to take part in the second round of talks on June 2.
Russia's Foreign Minister Sergei Lavrov on Wednesday publicly invited Ukraine to hold direct negotiations with Moscow on that date. In a video statement, Lavrov said Russia would use Monday's meeting to deliver an outline of Moscow's position on 'reliably overcoming' what it calls the root causes of the war. Russian officials have said for weeks that such a document is forthcoming.
Ukrainian Defense Minister Rustem Umerov on Wednesday said that Ukraine isn't opposed to further direct talks with Russia, but that they would be 'empty' if Moscow were to fail to clarify its terms. Umerov said he had personally handed a document setting out Ukraine's position to the Russian side.
Low-level delegations from Russia and Ukraine held their first direct peace talks in three years in Istanbul on May 16. The talks, which lasted two hours, brought no significant breakthrough, although both sides agreed to the largest prisoner exchange of the war. It was carried out last weekend and freed 1,000 captives on each side.
Fidan on Friday voiced a belief that the successful swap has 'proved that negotiations can yield concrete results.'
'There are two paths in front of us. Either we will turn a blind eye to the continuation of the war, or we will reach a lasting peace within the end of the year,' he told reporters in Kyiv.
___
Illia Novikov, The Associated Press
Associated Press writers Hanna Arhirova and Illia Novikov in Kyiv, Ukraine, and Suzan Fraser in Ankara, Turkey, contributed to this report.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
7 hours ago
- Globe and Mail
Bachem Mourns the Loss of Company Founder Dr. H.C. Peter Grogg
Bubendorf, Switzerland--(Newsfile Corp. - June 3, 2025) - The founder and honorary chairman of Bachem (SIX: BANB) Peter Grogg, passed away on Monday, June 2, 2025, at the age of 83. Peter Grogg founded Bachem in 1971 and built the company from a two-person operation into the global market leader for the chemical synthesis of peptides. Peter Grogg was CEO of the company for over 30 years until 2002 and Chairman of the Board of Directors of Bachem Holding AG until 2012. His daughter Nicole Grogg Hötzer has served as Vice-Chairwoman of the Board since 2011. For his achievements and merits in the field of peptides, Peter Grogg was awarded an honorary doctorate by the University of Basel. Kuno Sommer, Chairman of the Board of Directors of Bachem: "With Peter Grogg, we have lost a great entrepreneur. His drive and values made Bachem an internationally successful company and have left a lasting mark on it. In doing so, he has written a chapter of Swiss economic history. On behalf of the Board of Directors, the Executive Committee, and all employees of Bachem, I would like to express our deepest condolences to his wife, his two children, and their families." About Bachem Bachem is a leading, innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides. The company, which has over 50 years of experience and expertise, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide and offers a comprehensive range of services. Bachem operates internationally with its headquarters in Switzerland and sites in Europe, the US and Asia. The company is listed on the SIX Swiss Exchange. For further information, see This publication may contain specific forward-looking statements, e.g. statements including terms like "believe", "assume", "expect", "forecast", "project", "may", "could", "might", "will" or similar expressions. Such forward-looking statements are subject to known and unknown risks, uncertainties and other factors which may result in a substantial divergence between the actual results, financial situation, development or performance of Bachem Holding AG and those explicitly or implicitly presumed in these statements. Against the background of these uncertainties, readers should not rely on forward-looking statements. Bachem Holding AG assumes no responsibility to up-date forward-looking statements or to adapt them to future events or developments. To view the source version of this press release, please visit
CTV News
8 hours ago
- CTV News
One of the world's most notorious pathogens has survived for centuries. Scientists say they now know why
Researchers have announced that they've discovered what allowed the bacterium Yersinia pestis, the cause of the Black Death, to keep its hosts alive longer. (BSIP/Universalvia CNN Newsource) One of the bleakest periods in medieval Europe was the plague pandemic known as the Black Death, which killed at least 25 million people in just five years. But the disease didn't stop there. The plague adapted to keep its hosts alive longer, so it could spread farther and keep infecting people for centuries, and researchers now say they've discovered how. The disease is caused by the bacterium Yersinia pestis, which has been circulating among human populations for at least 5,000 years. The pathogen has fueled three major plague pandemics since the first century AD, and though its deadliest years appear to be behind us, plague hasn't disappeared. Cases still occur a few times a year in Asia, South America and the United States and more commonly in parts of Africa, according to the Cleveland Clinic, and can be treated with antibiotics. Scientists are still searching for answers about how Y. pestis evolved and dispersed, but recent analysis of ancient and modern Y. pestis samples revealed how plague managed to persist among humans for hundreds of years after pandemic waves petered out. After an initial period of high infection rates and rapid mortality — killing infected people within three days — changes to just one gene in the bacterium produced new strains that were less deadly and more transmissible, according to research published Thursday in the journal Science. Those weakened strains eventually went extinct; the dominant lineage of today's Y. pestis is the deadlier variety, the study authors reported. However, these findings about historic instances of Y. pestis adaptation could provide important clues to help scientists and physicians manage modern plague outbreaks. Trio of outbreaks Plague's most common form is bubonic plague, which causes painful swelling in lymph nodes and spreads among people through bites from fleas hitchhiking on infected rats. An outbreak of bubonic plague from 1347 to 1352 in Europe famously killed about 30% to 50% of the continent's population. But the earliest known bubonic plague outbreak — the Plague of Justinian — took hold in the Mediterranean Basin and lasted from AD 541 to AD 544. Another plague outbreak emerged in China in the 1850s and sparked a major epidemic in 1894. Scientists view modern plague cases as part of this third pandemic. For the new study, scientists collected ancient samples of Y. pestis from human remains dating back to about 100 years after the appearance of the first and second plague pandemics, sampling remains from Denmark, Europe and Russia. After reconstructing the genomes of these plague strains, they compared them with older, ancient strains that dated back to the start of plague pandemics. The researchers also examined more than 2,700 genomes of modern plague samples from Asia, Africa, and North and South America. One of the study coauthors, Jennifer Klunk, is a product scientist at Daciel Arbor Biosciences, a biotechnology company in Michigan that provided synthetically created molecules for the experiments, but there was no financial gain associated with the research. The researchers found that their newly reconstructed genomes from 100 years into the first two plague pandemics had fewer copies of a gene called pla, which has been recognized for decades as one of the factors that made plague so deadly, according to the study's co-lead author Ravneet Sidhu, a doctoral student in the McMaster Ancient DNA Centre at McMaster University in Hamilton, Ont. Pla encodes an enzyme that interacts with host proteins, 'and one of the functions that it carries out is in breaking down blood clots,' Sidhu told CNN. This ability helps Y. pestis spread into the host's lymph nodes, where it replicates before attacking the rest of the body. 'Not every function of this gene is fully known,' Sidhu added. However, prior studies by other researchers linked pla to severity of illness caused by both bubonic and pneumonic plague — an airborne form of the disease that affects the lungs, she said. While the reconstructed strains showed fewer copies of the pla gene, the scientists were still uncertain whether that would directly affect how deadly the disease could be. So they tested strains of reduced-pla bubonic plague on mice, and found that survival rates for this type of plague were 10 to 20 percent higher in those experiment subjects than in mice infected with Y. pestis that had a normal amount of the pla gene. It also took the reconstructed bubonic strain about two days longer to kill its hosts. 'The paper presents a strong argument that depletion, but not total loss, of Pla (the enzyme produced by the pla gene) is part of the evolution of the plague pathogen and may help explain the decline of plague in the second pandemic commonly known as the Black Death,' said Dr. Deborah Anderson, a professor of veterinary pathobiology at the University of Missouri's College of Veterinary Medicine. Anderson, who was not involved in the new research, investigates the virulence of plague, and these findings could shed light on transmission patterns in modern cases, she told CNN in an email. 'Our laboratory studies the flea-rodent cycle and we have collaborators who conduct field research in areas that experience annual or occasional plague outbreaks in the wild,' Anderson said. 'There are nearly 300 rodent species that can transmit Yersinia pestis, and today, burrowing rodents such as prairie dogs or ground squirrels are considered key animal hosts that experience outbreaks of disease,' she added. 'After reading this paper, we will pay closer attention to Pla in the future to see if there continues to be a role for its expression in driving the explosive outbreaks of plague in the animal populations.' Yersinia pestis study Co-lead study author Ravneet Sidhu examines a human tooth at McMaster University's Ancient DNA Centre in Hamilton, Ont. (McMaster University via CNN Newsource) 'Epidemic burnout' Mathematical models suggested how this might have played out in human populations centuries ago, leading to an 'epidemic burnout' about 100 years after a bubonic plague outbreak. In a pandemic's early stages, infections were swift, and death came quickly for both rats and humans. Over time, as dense rat populations thinned out, selective pressures favored the emergence of a less deadly strain of Y. pestis, with fewer copies of the pla gene. Rat hosts infected with this new strain would have a little more time to carry the disease, potentially enabling them to infect more rats — and more people. 'They suggest a model that can be readily pursued in the laboratory that may help explain the spread of plague today in the wild,' Anderson said. These weaker strains of the disease eventually sputtered out and went extinct. In the modern samples, the researchers found just three examples of strains with reduced pla genes, from Vietnam: one from a human subject and two from black rats (Rattus rattus). 'We've been able to do this really cool interdisciplinary study between the modern and ancient data and marry these things that have been happening throughout (the plague's) long evolutionary history,' Sidhu said. 'It could be interesting to see how future researchers continue to try and bridge that gap between the modern third pandemic and those first and second ancient pandemics, to see other similarities. Because there aren't a lot of ancient pathogens that we have as much data on, as we do for Yersinia pestis.' One of the unusual features of plague pandemics is their persistence, and understanding how Y. pestis changed its infection patterns and survived over time could shed light on the adaptive patterns of modern pandemics such as Covid-19, she added. 'Even if we aren't experiencing it to the amount that we were in 2020 or 2021, the pathogen is in the background — still evolving and persisting.' By Mindy Weisberger, CNN
CBC
8 hours ago
- CBC
Titleholder Swiatek to face top-ranked Sabalenka in French Open women's semifinals
Four-time champion Iga Swiatek's 26th successive win at Roland-Garros on Tuesday set up a semifinal clash against top-ranked Aryna Sabalenka in what will be their first French Open meeting. Swiatek defeated Elina Svitolina 6-1, 7-5 to extend her impressive run. The consecutive wins record on the Parisian red clay is Chris Evert's 29. Sabalenka ousted Olympic champion Zheng Qinwen in straight sets to reach the Paris semifinals for the second time. She will face Swiatek on Thursday. Having been searching for her best form in recent months, Swiatek, who struggled in the previous round, was in total control in the opening set. She was made to work harder by her 13th-seeded Ukrainian rival in the second set, dropping her serve in the fourth game after hitting two straight unforced errors into the net. But Swiatek broke back immediately and took advantage of Svitolina's poor service game to break again with a thunderous forehand return and move up 6-5. Swiatek sealed the win with a final ace. Swiatek has won five of the six matches she's played on clay against Sabalenka, including a thrilling three-setter in Spain last year. "The Madrid final against her is one of the best and most exciting finals that I have played," said Swiatek, who has not won a title or reached a final since her victory at Roland-Garros last year. "It is always a challenge against Aryna. She really has a game for every surface." Sabalenka is trying to reach her sixth Grand Slam final, and first at Roland-Garros. "We've had a lot of great battles in the past," Sabalenka said. "I'm super excited to go out there and to fight and to do everything I need to get the win." Sabalenka shone on big points Sabalenka overcame a shaky start and windy conditions to prevail against Zheng 7-6 (3), 6-3 and extend her record against the Chinese star to 7-1. The score did not fully reflect the closeness of the quarterfinal, though, with so little separating the rivals. But Sabalenka demonstrated why she was No. 1, making the difference on big points, while Zheng struggled with her serve in tense moments. Sabalenka had lost her most recent match against Zheng last month in Rome, having previously dominated their first six encounters. She said that loss was a good thing in the middle of an already exhausting season. "I was actually glad I lost that match, because I needed a little break before Roland-Garros," Sabalenka said. "Today, I was just more fresh. I was ready to battle; I was ready to leave everything I had on court to get this win." Sabalenka, a three-time major champion, has yet to drop a set in Paris. Zheng started strong on Court Philippe-Chatrier, breaking early and dominating with aggressive play. However, two double faults in the eighth game allowed Sabalenka to break back and shift the momentum. A misjudged call by Zheng in the 12th game nearly cost her, but she fought off a set point to force a tiebreaker. Sabalenka remained more consistent and secured the set after Zheng hit long on a drop shot. Zheng saved a break point with an overhead shot in the fifth game of the second set, but Sabalenka's powerful backhand return pinned her down on the next one, allowing the top-ranked player to move ahead 3--2. Zheng did not go down without a fight, though, and broke back immediately, only to drop her two last service games. The loss ended a run of 10 consecutive match wins for Zheng at Roland-Garros, dating to last summer's Olympic Games.
